|
|
||||||||




* Department of Medicine, Division of Rheumatology and Immunology, Medical Research Service, Ralph H. Johnson Veterans Affairs Medical Center, and
Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425; and
University of Miami School of Medicine, Miami, FL 33136
Increased Fli-1 mRNA is present in PBLs from systemic lupus erythematosus patients, and transgenic overexpression of Fli-1 in normal mice leads to a lupus-like disease. We report in this study that MRL/lpr mice, an animal model of systemic lupus erythematosus, have increased splenic expression of Fli-1 protein compared with BALB/c mice. Using mice with targeted gene disruption, we examined the effect of reduced Fli-1 expression on disease development in MRL/lpr mice. Complete knockout of Fli-1 is lethal in utero. Fli-1 protein expression in heterozygous MRL/lpr (Fli-1+/) mice was reduced by 50% compared with wild-type MRL/lpr (Fli-1+/+) mice. Fli-1+/ MRL/lpr mice had significantly decreased serum levels of total IgG and anti-dsDNA Abs as disease progressed. Fli-1+/ MRL/lpr mice had significantly increased splenic CD8+ and naive T cells compared with Fli-1+/+ MRL/lpr mice. Both in vivo and in vitro production of MCP-1 were significantly decreased in Fli-1+/ MRL/lpr mice. The Fli-1+/ mice had markedly decreased proteinuria and significantly lower pathologic renal scores. At 48 wk of age, survival was significantly increased in the Fli-1+/ MRL/lpr mice, as 100% of Fli-1+/ MRL/lpr mice were alive, in contrast to only 27% of Fli-1+/+ mice. These findings indicate that Fli-1 expression is important in lupus-like disease development, and that modulation of Fli-1 expression profoundly decreases renal disease and improves survival in MRL/lpr mice.
This article has been cited by other articles:
![]() |
J. Elkareh, S. M. Periyasamy, A. Shidyak, S. Vetteth, J. Schroeder, V. Raju, I. M. Hariri, N. El-Okdi, S. Gupta, L. Fedorova, et al. Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1219 - F1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. K. Zhang, O. Moussa, A. LaRue, S. Bradshaw, I. Molano, D. D. Spyropoulos, G. S. Gilkeson, and D. K. Watson The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice J. Immunol., August 1, 2008; 181(3): 1644 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. K. Zhang and D. K. Watson The FLI-1 Transcription Factor Is a Short-Lived Phosphoprotein in T Cells J. Biochem., March 1, 2005; 137(3): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |